- Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells
-
Kang DW, Min G, Park DY, Hong KW, Min DS
- KMID: 1104382
- Exp Mol Med.
- 2010 Aug;42(8):555-564.
- doi: 10.3858/emm.2010.42.8.056
Rebamipide a gastroprotective drug, is clinically used for the treatment of gastric ulcers and gastritis, but its actions on gastric cancer are not clearly understood. Phospholipase D (PLD) is overexpressed... -
- CITED
-
- Close
- SHARE
-
- Close
- Cyclooxygenase 2 in Gastric Carcinoma Is Expressed in Doublecortin- and CaM Kinase-Like-1-Positive Tuft Cells
-
Mutoh H, Sashikawa , Sakamoto H, Tateno T
- KMID: 2070061
- Gut Liver.
- 2014 Sep;8(5):508-518.
- doi: 10.5009/gnl13237
BACKGROUND/AIMS: Doublecortin and CaM kinase-like-1 (DCAMKL1) is a marker of stem cells expressed predominantly in the crypt base in the intestine. However, DCAMKL1-positive cells have been shown to be differentiated... -
- CITED
-
- Close
- SHARE
-
- Close
- Decreased Expression of 15-hydroxyprostaglandin Dehydrogenase in Gastric Carcinomas
-
Jang TJ, Ji YS, Jung KH
- KMID: 1782939
- Yonsei Med J.
- 2008 Dec;49(6):917-922.
- doi: 10.3349/ymj.2008.49.6.917
PURPOSE: Gastric carcinoma tissues release high level of prostaglandin E2 (PGE2) when compared to non-neoplastic mucosa, and cyclooxygenase-2 (COX-2), which is the rate-limiting enzyme in prostaglandin (PG) biosynthesis, is often... -
- CITED
-
- Close
- SHARE
-
- Close
